Evidence quality 4.88/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Kidney failure rarely ranks highly in surveys of health fears, despite being among the most burdensome chronic conditions in US medicine. Most people associate dialysis with a distant, elderly relative rather than themselves. Awareness is generally low among those without diabetes or hypertension -- the two conditions that account for nearly 70% of ESRD cases.
Rough estimate: Most people without chronic disease would guess under 1% lifetime -- substantially below the actual 3-4%
Source: editorial intuition, not polled
Actual
~130,000 new ESRD cases per year in the US
US adults
Show derivation
Albertus et al. (2016, Am J Kidney Dis) calculated lifetime risk of ESRD from birth using 2013 USRDS data, reporting 4.0% for males and 2.8% for females in 2013 (up from 3.5% and down from 3.0% respectively in 2000). Using 3.5% as a round central estimate consistent with the published range (2.0%--8.0% by race/sex subgroup) gives lifetime_us_adult = 0.035. This is a prevalence-based lifetime risk, not derived from simple annual-rate compounding, and directly reflects the Albertus 2016 published result rather than a naive calculation from the current annual incidence.
Caveats: The 3.5% figure is a lifetime cohort risk calculated from the 2013 USRDS registr…
The 3.5% figure is a lifetime cohort risk calculated from the 2013 USRDS registry. ESRD rates have changed over time: the incidence rate peaked around 2001 and has modestly declined through improved diabetes and hypertension management, though the absolute number of people on dialysis continues to rise with an aging population. The racial disparity is large and well-documented: a Black American faces roughly 2.5 times the lifetime ESRD risk of a white American, driven by higher rates of hypertension and diabetes, differential access to primary care, and possible genetic factors (APOL1 gene variants). This entry does not cover acute kidney injury (AKI) from which most patients recover; it specifically covers kidney failure requiring dialysis or transplant for survival.
Related risks
Other risks on similar themes — for exploring related fears.
Decisions this risk informs
Choices that turn on this risk — how people weigh the trade-off.
Dialysis vs. conservative care
% who regret this choice
Action dominates
Action regret 3.8× higher
Pick challenger
End-stage renal disease — kidney failure requiring dialysis or transplant for survival — affects more Americans than most people realize. The USRDS records roughly 130,000 new cases per year in the United States; about 808,000 Americans are currently living with ESRD. Published lifetime risk analysis by Albertus et al. (2016, Am J Kidney Dis) using USRDS data reports lifetime ESRD risk from birth ranging from 2.0% for non-Hispanic white women to 8.0% for non-Hispanic Black men — a population-weighted central estimate of roughly 1 in 29 for a typical US adult.
The risk is not evenly distributed. Diabetes accounts for roughly 40% of new ESRD cases and hypertension for another 28%; someone with both conditions faces a lifetime risk an order of magnitude above the population average. Racial disparities are among the largest in US medicine: non-Hispanic Black men face a lifetime ESRD risk of 8.0%, versus 3.1% for non-Hispanic white men — a 2.5-fold difference driven by higher hypertension prevalence, differential access to early nephrology care, and genetic risk factors including the APOL1 gene variant. The lifetime risk for non-Hispanic Black women (6.8%) is also far above the white female average (2.0%).
Once established, ESRD requires permanent treatment: approximately 70% of patients receive chronic dialysis (typically three sessions per week, four or more hours each) and 30% have a functioning kidney transplant. The dialysis burden is substantial — it imposes constraints on travel, diet, and employment that persist for the rest of the patient’s life unless a transplant becomes available. The kidneys are the only major organ for which there is no partial medical substitute once function is irreversibly lost; ESRD is therefore not merely a health risk but a fundamental alteration of daily life.
Related tidbits
Among elderly or frail kidney-failure patients, ~30% express significant regret about starting dialysis, mostly in the first year. About 10% of those who chose conservative management later regret not trying it.
Reaching end-stage renal disease — needing dialysis or a transplant — runs about 1 in 29 over a US adult lifetime, on roughly 130,000 new cases a year. Most people without chronic illness guess well under 1%.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
1/2 sources independently verified verbatim against the cited source
-
[1] American Journal of Kidney Diseases (Albertus, Morgenstern, Robinson & Saran, 2016) — Risk of ESRD in the United States Verified
Risk of ESRD in the United States- Statistic
Lifetime risk of ESRD from birth: 3.1% non-Hispanic white men, 8.0% non-Hispanic Black men, 2.0% non-Hispanic white women, 6.8% non-Hispanic Black women (2013 USRDS data)- Excerpt
“"Among males, the lifetime risks of ESRD from birth using 2013 data were 3.1% (95% CI, 3.0%-3.1%) for non-Hispanic (NH) whites, 8.0% (95% CI, 7.9%-8.2%) for NH blacks... Among females, the lifetime risks were 2.0% (95% CI, 2.0%-2.1%) for NH whites, 6.8% (95% CI, 6.7%-6.9%) for NH blacks. The lifetime risk of ESRD from birth increased from 3.5% in 2000 to 4.0% in 2013 in males and decreased from 3.0% to 2.8% in females." ”
- Source data from
- 2016-01-01
- Accessed
- 2026-05-14 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- Published lifetime risk figures are used directly without recalculation. The population-weighted average across sex and race groups approximates 3.3--3.5%. Using 3.5% as the central estimate for lifetime_us_adult = 0.035. The racial disparity is substantial: non-Hispanic Black men face ~2.5x the ESRD risk of non-Hispanic white men (8.0% vs 3.1%), which is reflected in personal_factor_multipliers.
- Independence
- Albertus et al. (2016) used the USRDS (United States Renal Data System) registry, which is the authoritative national database for ESRD incidence and prevalence, maintained by NIDDK. This analysis is independent of insurance claims data and represents a frequently cited academic source for US lifetime ESRD risk.
-
[2] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Kidney Disease Statistics for the United States
Kidney Disease Statistics for the United States- Statistic
~808,000 Americans living with ESRD; ~130,000 new ESRD cases per year; ~70% on dialysis, ~30% with functioning kidney transplant- Excerpt
“"In 2019, more than 808,000 Americans were living with ESRD. More than 131,000 people began treatment for kidney failure in 2019. About 70 percent of ESRD patients receive dialysis and about 30 percent have a functioning kidney transplant." ”
- Source data from
- 2022-01-01
- Accessed
- 2026-05-14 · archived copy
- Calculation
- 130,000 new cases per year / 260 million US adults = 0.0005 per adult per year. Over 59 years: 1 − (1 − 0.0005)^59 ≈ 0.028. This independent calculation from the annual incidence rate yields ~2.8%, broadly consistent with the Albertus et al. (2016) lifetime risk estimate of 3.5% (which uses a cohort method and is slightly higher because it captures risk from birth through the full lifespan). The Albertus figure is used as the primary estimate because it was specifically designed to measure lifetime risk.
- Independence
- NIDDK maintains the USRDS and provides national-level statistics independently of the Albertus et al. (2016) academic analysis. The two sources draw on the same underlying USRDS registry data but are independently published by a government agency and an academic research team respectively.